These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Toremifene and letrozole for advanced breast cancer. Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744 [No Abstract] [Full Text] [Related]
6. [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard]. Jonat W MMW Fortschr Med; 2006 Mar; 148(12):10. PubMed ID: 16625996 [No Abstract] [Full Text] [Related]
7. The role of aromatase inhibitor (AI) in the treatment of breast cancer. Irawan C; Abdulmuthalib Acta Med Indones; 2005; 37(1):43-8. PubMed ID: 15879638 [No Abstract] [Full Text] [Related]
8. Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective. Garreau JR; Delamelena T; Walts D; Karamlou K; Johnson N Am J Surg; 2006 Oct; 192(4):496-8. PubMed ID: 16978958 [TBL] [Abstract][Full Text] [Related]
9. [Toxicity of aromatase inhibitor]. Miyashita M; Ishida T; Ohuchi N Nihon Rinsho; 2015 Feb; 73 Suppl 2():302-7. PubMed ID: 25831772 [No Abstract] [Full Text] [Related]
10. Do all aromatase inhibitors have similar efficacy and safety? Şendur MA; Bilgin B; Hızal M; Özdemir NY; Akıncı MB; Dede DŞ; Yalçın B Future Oncol; 2017 Aug; 13(19):1673-1676. PubMed ID: 28831832 [No Abstract] [Full Text] [Related]
11. Adjuvant endocrine therapy for breast cancer: don't ditch the switch! Puhalla S; Jankowitz RC; Davidson NE J Natl Cancer Inst; 2011 Sep; 103(17):1280-2. PubMed ID: 21859987 [No Abstract] [Full Text] [Related]
12. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer]. Tuxen MK; Nielsen DL; Lindberg H; Kamby C Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922 [TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of concurrent vs. sequential administration of radiotherapy and hormone therapy using aromatase inhibitor for hormone receptor-positive postmenopausal breast cancer. Ishitobi M; Komoike Y; Motomura K; Koyama H; Nishiyama K; Inaji H Anticancer Res; 2009 Nov; 29(11):4791-4. PubMed ID: 20032437 [TBL] [Abstract][Full Text] [Related]
14. Hormonal therapy for advanced breast cancer. Rugo HS Hematol Oncol Clin North Am; 2007 Apr; 21(2):273-91. PubMed ID: 17512449 [TBL] [Abstract][Full Text] [Related]
15. Management of bone disease in patients undergoing hormonal therapy for breast cancer. Mirza FS Endocrinol Metab Clin North Am; 2011 Sep; 40(3):549-62, viii. PubMed ID: 21889720 [TBL] [Abstract][Full Text] [Related]
16. [Aromatase inhibitors for metastasing breast cancer in postmenopausal women. A survey of a Cochrane review]. Aziz M; Skougaard K; Kamby C; Nielsen DL Ugeskr Laeger; 2008 Jun; 170(25):2248-52. PubMed ID: 18565316 [No Abstract] [Full Text] [Related]
17. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB Breast J; 2006; 12(2):114-22. PubMed ID: 16509835 [TBL] [Abstract][Full Text] [Related]
19. Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women. Parton M; Smith IE J Clin Oncol; 2008 Feb; 26(5):745-52. PubMed ID: 18258982 [No Abstract] [Full Text] [Related]